Statin use linked to lower mortality after heart muscle injury
One-year mortality was 11.5% among patients started on statins in hospital versus 27.5% among those not started on them in the main cohort.
Independent replication, multicenter
Limit: The abstract did not report participants' ages, statin doses, or adverse events
Edited by Boris Djordjevic · AgingResearch.News
Researchers analyzed records from 50,670 patients with acute heart muscle injury unrelated to reduced blood flow who had not previously used statins, cholesterol-lowering drugs. This retrospective observational study compared patients who started statins in hospital with those who did not. Researchers also analyzed a separate critical-care cohort of 10,893 patients.
After adjustment for measured differences, statin use remained associated with lower one-year mortality in both cohorts. In the critical-care cohort, one-year mortality was 29.1% with statins and 41.1% without them. In the main cohort, statin use was also linked to lower cardiovascular, cancer-related and respiratory mortality. Both earlier and later starts were associated with lower mortality.
Why it matters
For cardiovascular care in later life, the study addresses an unmet need: drug options after acute heart muscle injury unrelated to reduced blood flow.
Caveats
This observational study cannot show that statins caused lower mortality; differences between patients may remain despite adjustment. The conference abstract did not report participants’ ages, statin doses or adverse events.
The paper
Statin therapy and 1-year mortality in non-ischaemic acute myocardial injury: a dual-cohort study
Tianjin Medical University General Hospital
ESC Congress 2026 Abstract, Oct 26, 2026
Presented at ESC Congress 2026
